Norbert Bischofberger
Chief Executive Officer at KRONOS BIO, INC.
Net worth: 8 M $ as of 2024-02-28
Profile
Dr. Norbert W.
Bischofberger is an Independent Director at Morphic Holding, Inc., a President, Chief Executive Officer & Director at Kronos Bio, Inc., an Independent Member-Supervisory Board at Bayer AG and a Scientific Advisor at VV Manager LLC.
He is on the Board of Directors at Rezo Therapeutics, Inc., Morphic Therapeutic, Inc., Morphic Holding, Inc., Kronos Bio, Inc. and Bayer AG.
Dr. Bischofberger was previously employed as a Chief Scientific Officer & Executive VP- Research by Gilead Sciences, Inc. and a Manager-DNA Synthesis Group by Genentech, Inc. He also served on the board at InCarda Therapeutics, Inc. He received his undergraduate degree from the University of Innsbruck and a doctorate degree from Swiss Federal Institute of Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
KRONOS BIO INC
12.77% | 2024-02-14 | 7,445,248 ( 12.77% ) | 8 M $ | 2024-02-28 |
MORPHIC HOLDING, INC.
-.--% | 2023-05-31 | 0 ( -.--% ) | - $ | 2024-02-28 |
Norbert Bischofberger active positions
Companies | Position | Start |
---|---|---|
BAYER AG | Director/Board Member | 2017-03-31 |
KRONOS BIO, INC. | Chief Executive Officer | 2018-07-31 |
MORPHIC HOLDING, INC. | Director/Board Member | 2019-05-31 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director/Board Member | 2019-06-13 |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Founder | 2022-11-16 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
Former positions of Norbert Bischofberger
Companies | Position | End |
---|---|---|
GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2018-04-29 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 1989-12-31 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Director/Board Member | - |
Training of Norbert Bischofberger
University of Innsbruck | Undergraduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
BAYER AG | Health Technology |
KRONOS BIO, INC. | Health Technology |
Private companies | 6 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Morphic Holding, Inc. | |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Finance |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Commercial Services |